{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18144", "batch_size": 200, "batch_pos": 155, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment contains a neutral statement about trial timing.", "method": "llm_batch", "batch_id": "batch_2_14416", "batch_size": 200, "batch_pos": 149, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "No moderate verb paired with explicit scale/impact information.", "method": "llm_batch", "batch_id": "batch_3_16912", "batch_size": 200, "batch_pos": 111, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment is not a question.", "method": "llm_batch", "batch_id": "batch_4_19964", "batch_size": 200, "batch_pos": 107, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment states future testing, lacking explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_11600", "batch_size": 200, "batch_pos": 105, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_12472", "batch_size": 200, "batch_pos": 97, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_16888", "batch_size": 200, "batch_pos": 95, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes a future plan/timeline ('late-stage testing would begin in 2025'), which is a future plan/preparedness measure, without calming keywords.", "method": "llm_batch", "batch_id": "batch_8_19332", "batch_size": 200, "batch_pos": 59, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
